Varian, Inc. attracted to MR supplier
This article was originally published in The Gray Sheet
Executive Summary
$32 mil. purchase of UK-based Magnex Scientific follows September acquisition of Digilab spectroscopy assets for $14 mil., marking step toward Varian's goal of executing $150 mil. in combinations over three years, Palo Alto firm says Oct. 11. Over that period, Varian aims to generate $1 bil. in annual revenue from scientific instruments and grow operating margins from 11% to 15%. "A trend of MR imaging has been ever-increasing field strength that requires larger and larger magnets," CEO Garry Rogerson explains. "If we are to integrate the magnets into the total system, we need to have control of the development and cost." The Magnex deal includes potential milestone payments for three years. Varian estimates Magnex shipments will total $25 mil.-$28 mil. over 12 months, with roughly 7%-8% likely to support scientific instruments R&D...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.